Literature DB >> 19635555

Hyaluronan synthases and hyaluronidases in the kidney during changes in hydration status.

Louise Rügheimer1, Johan Olerud, Cecilia Johnsson, Tomoko Takahashi, Kei Shimizu, Peter Hansell.   

Abstract

Hyaluronan is a large glycosaminoglycan that is abundant in the interstitium of the renal medulla/papilla. Papillary hyaluronan increases during hydration and decreases during dehydration. Due to its gel properties and ability to retain large volumes of water, hyaluronan plays a role in renal water handling by affecting the permeability characteristics of the papillary interstitium. The focus of the present investigation was the regulation of hyaluronan metabolism in the kidney, especially during variations in hydration status. In control papillas, HAS 2 mRNA was heavily expressed and HAS 1 and 3 mRNA were weakly distributed. HYALs 1-3 mRNA were found at high expression and HYAL 4 was only weakly expressed. In hydrated animals, the diuretic response (12-fold) was followed by a 58% elevation in papillary hyaluronan and a 45% reduction in the excreted urinary hyaluronidase activity. No difference was determined in HAS 1-3 mRNA or HYAL 1, 3-4 mRNA expression, suggesting a change in activity rather than amount of protein. In dehydrated animals, antidiuresis was followed by a 22% reduction in papillary hyaluronan and a 62% elevation in excreted urinary hyaluronidase activity. Plasma vasopressin was 2.8-fold higher in dehydrated vs. hydrated rats. In conclusion, HAS 2 appears a major contributor to the baseline levels of hyaluronan. Reduced HAS 2 gene expression and increased excreted urinary hyaluronidase activity during dehydration contribute to the reduced amount of hyaluronan and to antidiuretic response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635555     DOI: 10.1016/j.matbio.2009.07.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  6 in total

1.  Evaluation of cardiovascular toxicity of carbon nanotubes functionalized with sodium hyaluronate in oral regenerative medicine.

Authors:  J V Joviano-Santos; M A Sá; M L A de Maria; T C S Almeida; V Geraldo; S Oliveira; L O Ladeira; A J Ferreira
Journal:  Braz J Med Biol Res       Date:  2014-05-23       Impact factor: 2.590

2.  Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan.

Authors:  Sara Stridh; Fredrik Palm; Tomoko Takahashi; Mayumi Ikegami-Kawai; Peter Hansell
Journal:  Ups J Med Sci       Date:  2015-07-14       Impact factor: 2.384

3.  Hyaluronan Production by Renomedullary Interstitial Cells: Influence of Endothelin, Angiotensin II and Vasopressin.

Authors:  Sara Stridh; Fredrik Palm; Tomoko Takahashi; Mayumi Ikegami-Kawai; Malou Friederich-Persson; Peter Hansell
Journal:  Int J Mol Sci       Date:  2017-12-13       Impact factor: 5.923

4.  Highly suggestive preliminary evidence that the renal interstitium contracts in vivo.

Authors:  Omar Flores-Sandoval; María Eugenia Sánchez-Briones; Juan F López-Rodríguez; Miriam Z Calvo-Turrubiartes; Lilia Llamazares-Azuara; Manuel Rodríguez-Martínez
Journal:  Physiol Rep       Date:  2017-06

5.  High-molecular weight hyaluronan attenuates tubulointerstitial scarring in kidney injury.

Authors:  Xinyi Wang; Swathi Balaji; Emily H Steen; Alexander J Blum; Hui Li; Christina K Chan; Scott R Manson; Thomas C Lu; Meredith M Rae; Paul F Austin; Thomas N Wight; Paul L Bollyky; Jizhong Cheng; Sundeep G Keswani
Journal:  JCI Insight       Date:  2020-06-18

6.  Inhibition of hyaluronan synthesis in rats reduces renal ability to excrete fluid and electrolytes during acute hydration.

Authors:  Sara Stridh; Fredrik Palm; Peter Hansell
Journal:  Ups J Med Sci       Date:  2013-09-09       Impact factor: 2.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.